TRACON Pharmaceuticals Inc (TCON) Stock: Evaluating the Market Performance
Moreover, the 36-month beta value for TCON is 1.19. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 3
Moreover, the 36-month beta value for TCON is 1.19. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 3
The stock price of TRACON Pharmaceuticals Inc (NASDAQ: TCON) has plunged by -14.10 when compared to previous closing price of 0.26, but the company has
The stock has a 36-month beta value of 1.04. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 3 as
The stock of TRACON Pharmaceuticals Inc (TCON) has gone up by 27.39% for the week, with a 176.94% rise in the past month and a
TRACON Pharmaceuticals Inc (NASDAQ: TCON)’s stock price has soared by 12.13 in relation to previous closing price of 0.44. Nevertheless, the company has seen a
The stock price of TRACON Pharmaceuticals Inc (NASDAQ: TCON) has dropped by -14.31 compared to previous close of 0.44. Despite this, the company has seen
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.